CASP1 and colitis: It was also demonstrated that the deletion of the inflammasome component caspase-1 that is involved in the production of the active forms of IL-1β and IL-18 (51) or the blockade of IL-1β or IL-18 signaling (52, 53) significantly attenuates the severity of DSS-induced colitis in mice.